A second phase 2a, dose escalation study of Factor VIIa-CTP in patients with haemophilia A or B
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2016
At a glance
- Drugs Factor VIIa-CTP (Primary) ; Factor VIIa-CTP (Primary)
- Indications Haemophilia A; Haemophilia B
- Focus Adverse reactions; First in man
- Sponsors OPKO Health
- 07 Nov 2016 According to an OPKO health media release, safety data from this trial expected in early 2017.
- 29 Feb 2016 According to an OPKO health media release, first patient has been dosed in this trial.
- 29 Feb 2016 Status changed from not yet recruiting to recruiting, according to an OPKO Health media release.